- Home
- COCH vs ANTX Comparison
COCH vs ANTX Comparison
Compare COCH & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- ANTX
- Stock Information
- Founded
- COCH 1995
- ANTX 2017
- Country
- COCH United States
- ANTX United States
- Employees
- COCH N/A
- ANTX N/A
- Industry
- COCH Blank Checks
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- ANTX Health Care
- Exchange
- COCH Nasdaq
- ANTX Nasdaq
- Market Cap
- COCH 31.6M
- ANTX 33.2M
- IPO Year
- COCH N/A
- ANTX 2022
- Fundamental
- Price
- COCH $1.50
- ANTX $1.07
- Analyst Decision
- COCH Strong Buy
- ANTX Buy
- Analyst Count
- COCH 2
- ANTX 2
- Target Price
- COCH $9.25
- ANTX $2.00
- AVG Volume (30 Days)
- COCH 20.0K
- ANTX 287.0K
- Earning Date
- COCH 08-11-2025
- ANTX 08-12-2025
- Dividend Yield
- COCH N/A
- ANTX N/A
- EPS Growth
- COCH N/A
- ANTX N/A
- EPS
- COCH N/A
- ANTX N/A
- Revenue
- COCH $212,000.00
- ANTX N/A
- Revenue This Year
- COCH $8.04
- ANTX N/A
- Revenue Next Year
- COCH $15.39
- ANTX N/A
- P/E Ratio
- COCH N/A
- ANTX N/A
- Revenue Growth
- COCH N/A
- ANTX N/A
- 52 Week Low
- COCH $1.21
- ANTX $0.87
- 52 Week High
- COCH $3.99
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- COCH 51.65
- ANTX 45.19
- Support Level
- COCH $1.40
- ANTX $1.07
- Resistance Level
- COCH $1.59
- ANTX $1.11
- Average True Range (ATR)
- COCH 0.09
- ANTX 0.04
- MACD
- COCH 0.01
- ANTX 0.00
- Stochastic Oscillator
- COCH 62.22
- ANTX 28.57
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.